Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Board Changes

7 Jan 2016 07:00

RNS Number : 0807L
Persimmon PLC
07 January 2016
 

 

7 January 2016

Persimmon Plc

 

Board Changes

 

Persimmon Plc (the 'Company') announces that after almost 30 years of service, Nigel Greenaway, South Division Chief Executive has decided to retire from the Board after the conclusion of the Company's AGM on 14 April 2016. The Company is pleased to announce that David Jenkinson will be promoted to Group Managing Director with immediate effect, with responsibility for Group businesses and reporting directly to the Group Chief Executive, Jeff Fairburn.

 

In addition Richard Pennycook, Senior Independent Director and Mark Preston, Non-Executive Director have both informed the Company that they will resign from the Board at the conclusion of the Company's AGM on 14 April 2016. Nigel Mills, Senior Advisor, Citigroup Global Markets will join the Board as a Non-Executive Director from 4 April 2016, he will also become a member of the Remuneration Committee from the same date.

 

Nigel Greenaway has decided that after a long career with Persimmon he would now like to retire to pursue leisure interests and have more time with his family. Richard Pennycook, who has been a Non-Executive Director of the Company for almost eight years has decided to resign from the Board due to time commitments on his appointment as Chairman of Howden Joinery Group Plc from May 2016. Mark Preston has been a Non-Executive Director for four years and he has decided to resign from the Board, due to time commitments following his prospective promotion at the Grosvenor Estate.

 

Following these changes, the Board will consist of eight directors, the Chairman, three Executive Directors and four Non-Executive Directors.

 

Nicholas Wrigley, Chairman of Persimmon, said "We are delighted to welcome Nigel Mills to the Board. His financial, commercial and investor relations experience will add to the balance of skills and experience of our Non-Executive Directors, which will be of great benefit to Persimmon as we continue to develop our business.

 

The Board would like to express their thanks to Nigel Greenaway for his contribution to the success of the Company during a long and distinguished career and wish him a long and happy retirement. The Board would also like to express their thanks to Richard Pennycook and Mark Preston for their valuable contribution to the Company during their tenure."

 

No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

 

G N Francis

Group Company Secretary

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABIGDBIBGBGLL
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.